研報掘金丨中郵證券:青島啤酒持續深耕國內國際市場,維持“買入”評級
中郵證券研報指出,青島啤酒持續深耕國內國際市場,將銷量增長作爲首要目標任務,國內市場繼續堅定一縱兩橫的市場戰略。海外市場加速落地“一弧三翼多點”戰略佈局,聚焦韓國市場開展消費者主題活動,聚焦俄羅斯、蒙古、哈薩克斯坦以及西非地區國家等潛力市場拉動銷量快速增長。堅定不移的落地實施1+1+1+2+N的產品組合發展戰略。公司啤酒銷量有望在24年低基數的基礎上實現一定增長,同時25年全年成本有望繼續延續改善趨勢。預計未來三年EPS分別爲3.46/3.76/4.01元/股,對應當前股價PE分別爲20/18/17倍,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.